Donald Trump announced a plan to bring drug manufacturing back to the U.S., imposing zero tariffs on imported generics for ...

Trump's tariff roadmap for generic drug imports is aimed at encouraging pharmaceutical manufacturing in the US, with Indian ...

US Secretary of State Marco Rubio anticipates Indian concern over new generic drug import tariffs. These tariffs will rise ...

US Secretary of State Marco Rubio said India was likely to be concerned over President Donald Trump’s proposed tariffs on ...

US Secretary of State Marco Rubio highlighted India's potential concerns over Trump's proposed tariffs on imported generic ...

Possible outcomes: Tariffs could remain the same; rates could change depending on US investigations under Section 301; US could opt for a different instrument.

Indian drugmakers export around $9-10 billion worth of generic medicines to the American market every year.

Indian leader faces ‘perfect storm’ at home as proposed US trade deal sparks backlash and Trump ramps up pressure over Russian oil and China.

US President proposes zero tariff on imported generic medicines for two years before duties rise to 100% and later 200% to ...

US Secretary of State Marco Rubio acknowledged India’s concerns over Donald Trump’s proposed pharmaceutical tariffs, saying ...

Donald Trump is one of the most unpopular presidents in US history. According to recent opinion polls, Trump’s approval ...